T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBNY
326
DELISTED
Signature Bank
SBNY
| $386M | 0.06% |
3,364,021
+117,595
| +4% | +$13.9M |
|
327
Costco
COST
$427B
| $385M | 0.06% |
1,639,767
-197,622
| -11% | -$44.5M |
|
328
Ingersoll Rand
IR
$32.7B
| $383M | 0.06% |
13,518,886
+3,858,687
| +40% | +$108M |
|
|
GOOS
329
Canada Goose Holdings
GOOS
$850M
| $383M | 0.06% |
5,930,478
+602,106
| +11% | +$35.1M |
|
330
Emerson Electric
EMR
$91.6B
| $380M | 0.06% |
4,965,818
-270,223
| -5% | -$19.9M |
|
331
Diamondback Energy
FANG
$55.9B
| $380M | 0.06% |
2,811,522
-305,748
| -10% | -$39M |
|
332
Zimmer Biomet
ZBH
$19B
| $380M | 0.06% |
2,977,288
+523,715
| +21% | +$62.3M |
|
|
LOXO
333
DELISTED
Loxo Oncology, Inc
LOXO
| $380M | 0.06% |
2,222,837
+29,312
| +1% | +$4.93M |
|
|
AGN
334
DELISTED
Allergan plc
AGN
| $379M | 0.06% |
1,991,989
-330,754
| -14% | -$60.8M |
|
335
ONE Gas
OGS
$5.09B
| $377M | 0.06% |
4,583,371
+7,010
| +0.2% | +$549K |
|
336
Skyworks Solutions
SWKS
$10.5B
| $377M | 0.06% |
4,155,476
-311,324
| -7% | -$29.1M |
|
337
Kraft Heinz
KHC
$30.1B
| $371M | 0.05% |
6,730,298
+2,854,198
| +74% | +$171M |
|
|
SEM
338
DELISTED
Select Medical
SEM
| $370M | 0.05% |
37,370,547
+94,649
| +0.3% | +$980K |
|
339
Alnylam Pharmaceuticals
ALNY
$30.4B
| $368M | 0.05% |
4,200,755
-1,013,208
| -19% | -$102M |
|
340
Post Holdings
POST
$3.65B
| $366M | 0.05% |
5,696,520
+76,745
| +1% | +$4.71M |
|
341
C.H. Robinson
CHRW
$17.5B
| $363M | 0.05% |
3,702,846
-1,450,777
| -28% | -$136M |
|
342
Service Corp International
SCI
$11.3B
| $362M | 0.05% |
8,189,771
-815,692
| -9% | -$32.9M |
|
343
KKR & Co
KKR
$103B
| $362M | 0.05% |
13,256,556
+2,679,195
| +25% | +$71.6M |
|
344
PACCAR
PCAR
$68.8B
| $361M | 0.05% |
7,948,959
+1,840,672
| +30% | +$81.2M |
|
345
Guidewire Software
GWRE
$15.2B
| $361M | 0.05% |
3,572,463
-2,044,005
| -36% | -$196M |
|
346
CME Group
CME
$96.1B
| $360M | 0.05% |
2,115,718
+451,547
| +27% | +$76M |
|
347
Altria Group
MO
$109B
| $360M | 0.05% |
5,962,139
+366,717
| +7% | +$21.8M |
|
|
LLL
348
DELISTED
L3 Technologies, Inc.
LLL
| $359M | 0.05% |
1,688,627
+486,311
| +40% | +$101M |
|
349
Public Storage
PSA
$61.4B
| $359M | 0.05% |
1,779,509
-111,428
| -6% | -$24M |
|
350
NVR
NVR
$17B
| $359M | 0.05% |
145,135
+17,692
| +14% | +$48.8M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.